Disclosures for "Characterization of FTLD spectrum through advanced diffusion-weighted MRI metrics: a connectome approach")
-
Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
-
Silvia Basaia has nothing to disclose.
-
Dr. Facente has nothing to disclose.
-
Ms. Cividini has nothing to disclose.
-
Dr. Spinelli has nothing to disclose.
-
The institution of Elisa Canu has received research support from Italian Ministry of Health .
-
Dr. Castelnovo has nothing to disclose.
-
Giuseppe Magnani has nothing to disclose.
-
Dr. Caso has nothing to disclose.
-
Paola Caroppo has nothing to disclose.
-
Sara Prioni has nothing to disclose.
-
Miss Villa has nothing to disclose.
-
Lucio Tremolizzo has nothing to disclose.
-
Dr. Appollonio has nothing to disclose.
-
Dr. Silani has nothing to disclose.
-
Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).